Synthesis of the (5Z)-5-Pentacosenoic and 5-Pentacosynoic Acids as Novel HIV-1 Reverse Transcriptase Inhibitors

The natural fatty acids (5 Z )-5-pentacosenoic and (9 Z )-9-pentacosenoic acids were synthesized for the first time in eight steps starting from either 4-bromo-1-butanol or 8-bromo-1-butanol and in 20-58% overall yields, while the novel fatty acids 5-pentacosynoic and 9-pentacosynoic acids were also...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lipids 2015-09, Vol.50 (10), p.1043-1050
Hauptverfasser: Moreira, Lizabeth Giménez, Orellano, Elsie A., Rosado, Karolyna, Guido, Rafael V. C., Andricopulo, Adriano D., Soto, Gabriela O., Rodríguez, José W., Sanabria-Ríos, David J., Carballeira, Néstor M.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1050
container_issue 10
container_start_page 1043
container_title Lipids
container_volume 50
creator Moreira, Lizabeth Giménez
Orellano, Elsie A.
Rosado, Karolyna
Guido, Rafael V. C.
Andricopulo, Adriano D.
Soto, Gabriela O.
Rodríguez, José W.
Sanabria-Ríos, David J.
Carballeira, Néstor M.
description The natural fatty acids (5 Z )-5-pentacosenoic and (9 Z )-9-pentacosenoic acids were synthesized for the first time in eight steps starting from either 4-bromo-1-butanol or 8-bromo-1-butanol and in 20-58% overall yields, while the novel fatty acids 5-pentacosynoic and 9-pentacosynoic acids were also synthesized in six steps and in 34-43% overall yields. The Δ 5 acids displayed the best IC 50’s (24-38 µM) against the HIV-1 reverse transcriptase (RT) enzyme, comparable to nervonic acid (IC 50 = 12 µM). The Δ 9 acids were not as effective towards HIV-RT with the (9 Z )-9-pentacosenoic acid displaying an IC 50 = 54 µM. Fatty acid chain length and position of the unsaturation was critical for the observed inhibition. Molecular modeling studies indicated the structural determinants underlying the biological activity of the most potent compounds. These results provide new insights into the structural requirements that must be present in fatty acids so as to enhance their inhibitory potential towards HIV-RT.
doi_str_mv 10.1007/s11745-015-4064-2
format Article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4841444</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_4841444</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_48414443</originalsourceid><addsrcrecordid>eNqljU9LxDAUxIMobv3zAbzlqIdoXvvS7l4EkZXdi4guHryEbJq1kW5S8mqh394ignj2NDO_gRnGLkBeg5TVDQFUqIQEJVCWKPIDloFSc7EoZHXIMilzFJhLmLEToo8pAi7UMZvlZYGqxCpj8WUMfePIE487Pjl-qd6uhBJPLvTGRnIhestNqPkvG7_ZnfU1cUP8MQ6u5av1qwD-7AaXyPFNMoFs8l1vprQOjd_6PiY6Y0c705I7_9FTdvuw3NyvRPe53bvaTg_JtLpLfm_SqKPx-m8TfKPf46BxjoCIxb8HvgAQPWgI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synthesis of the (5Z)-5-Pentacosenoic and 5-Pentacosynoic Acids as Novel HIV-1 Reverse Transcriptase Inhibitors</title><source>Access via Wiley Online Library</source><source>SpringerNature Journals</source><creator>Moreira, Lizabeth Giménez ; Orellano, Elsie A. ; Rosado, Karolyna ; Guido, Rafael V. C. ; Andricopulo, Adriano D. ; Soto, Gabriela O. ; Rodríguez, José W. ; Sanabria-Ríos, David J. ; Carballeira, Néstor M.</creator><creatorcontrib>Moreira, Lizabeth Giménez ; Orellano, Elsie A. ; Rosado, Karolyna ; Guido, Rafael V. C. ; Andricopulo, Adriano D. ; Soto, Gabriela O. ; Rodríguez, José W. ; Sanabria-Ríos, David J. ; Carballeira, Néstor M.</creatorcontrib><description>The natural fatty acids (5 Z )-5-pentacosenoic and (9 Z )-9-pentacosenoic acids were synthesized for the first time in eight steps starting from either 4-bromo-1-butanol or 8-bromo-1-butanol and in 20-58% overall yields, while the novel fatty acids 5-pentacosynoic and 9-pentacosynoic acids were also synthesized in six steps and in 34-43% overall yields. The Δ 5 acids displayed the best IC 50’s (24-38 µM) against the HIV-1 reverse transcriptase (RT) enzyme, comparable to nervonic acid (IC 50 = 12 µM). The Δ 9 acids were not as effective towards HIV-RT with the (9 Z )-9-pentacosenoic acid displaying an IC 50 = 54 µM. Fatty acid chain length and position of the unsaturation was critical for the observed inhibition. Molecular modeling studies indicated the structural determinants underlying the biological activity of the most potent compounds. These results provide new insights into the structural requirements that must be present in fatty acids so as to enhance their inhibitory potential towards HIV-RT.</description><identifier>ISSN: 0024-4201</identifier><identifier>EISSN: 1558-9307</identifier><identifier>DOI: 10.1007/s11745-015-4064-2</identifier><identifier>PMID: 26345647</identifier><language>eng</language><ispartof>Lipids, 2015-09, Vol.50 (10), p.1043-1050</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids></links><search><creatorcontrib>Moreira, Lizabeth Giménez</creatorcontrib><creatorcontrib>Orellano, Elsie A.</creatorcontrib><creatorcontrib>Rosado, Karolyna</creatorcontrib><creatorcontrib>Guido, Rafael V. C.</creatorcontrib><creatorcontrib>Andricopulo, Adriano D.</creatorcontrib><creatorcontrib>Soto, Gabriela O.</creatorcontrib><creatorcontrib>Rodríguez, José W.</creatorcontrib><creatorcontrib>Sanabria-Ríos, David J.</creatorcontrib><creatorcontrib>Carballeira, Néstor M.</creatorcontrib><title>Synthesis of the (5Z)-5-Pentacosenoic and 5-Pentacosynoic Acids as Novel HIV-1 Reverse Transcriptase Inhibitors</title><title>Lipids</title><description>The natural fatty acids (5 Z )-5-pentacosenoic and (9 Z )-9-pentacosenoic acids were synthesized for the first time in eight steps starting from either 4-bromo-1-butanol or 8-bromo-1-butanol and in 20-58% overall yields, while the novel fatty acids 5-pentacosynoic and 9-pentacosynoic acids were also synthesized in six steps and in 34-43% overall yields. The Δ 5 acids displayed the best IC 50’s (24-38 µM) against the HIV-1 reverse transcriptase (RT) enzyme, comparable to nervonic acid (IC 50 = 12 µM). The Δ 9 acids were not as effective towards HIV-RT with the (9 Z )-9-pentacosenoic acid displaying an IC 50 = 54 µM. Fatty acid chain length and position of the unsaturation was critical for the observed inhibition. Molecular modeling studies indicated the structural determinants underlying the biological activity of the most potent compounds. These results provide new insights into the structural requirements that must be present in fatty acids so as to enhance their inhibitory potential towards HIV-RT.</description><issn>0024-4201</issn><issn>1558-9307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqljU9LxDAUxIMobv3zAbzlqIdoXvvS7l4EkZXdi4guHryEbJq1kW5S8mqh394ignj2NDO_gRnGLkBeg5TVDQFUqIQEJVCWKPIDloFSc7EoZHXIMilzFJhLmLEToo8pAi7UMZvlZYGqxCpj8WUMfePIE487Pjl-qd6uhBJPLvTGRnIhestNqPkvG7_ZnfU1cUP8MQ6u5av1qwD-7AaXyPFNMoFs8l1vprQOjd_6PiY6Y0c705I7_9FTdvuw3NyvRPe53bvaTg_JtLpLfm_SqKPx-m8TfKPf46BxjoCIxb8HvgAQPWgI</recordid><startdate>20150907</startdate><enddate>20150907</enddate><creator>Moreira, Lizabeth Giménez</creator><creator>Orellano, Elsie A.</creator><creator>Rosado, Karolyna</creator><creator>Guido, Rafael V. C.</creator><creator>Andricopulo, Adriano D.</creator><creator>Soto, Gabriela O.</creator><creator>Rodríguez, José W.</creator><creator>Sanabria-Ríos, David J.</creator><creator>Carballeira, Néstor M.</creator><scope>5PM</scope></search><sort><creationdate>20150907</creationdate><title>Synthesis of the (5Z)-5-Pentacosenoic and 5-Pentacosynoic Acids as Novel HIV-1 Reverse Transcriptase Inhibitors</title><author>Moreira, Lizabeth Giménez ; Orellano, Elsie A. ; Rosado, Karolyna ; Guido, Rafael V. C. ; Andricopulo, Adriano D. ; Soto, Gabriela O. ; Rodríguez, José W. ; Sanabria-Ríos, David J. ; Carballeira, Néstor M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_48414443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moreira, Lizabeth Giménez</creatorcontrib><creatorcontrib>Orellano, Elsie A.</creatorcontrib><creatorcontrib>Rosado, Karolyna</creatorcontrib><creatorcontrib>Guido, Rafael V. C.</creatorcontrib><creatorcontrib>Andricopulo, Adriano D.</creatorcontrib><creatorcontrib>Soto, Gabriela O.</creatorcontrib><creatorcontrib>Rodríguez, José W.</creatorcontrib><creatorcontrib>Sanabria-Ríos, David J.</creatorcontrib><creatorcontrib>Carballeira, Néstor M.</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Lipids</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moreira, Lizabeth Giménez</au><au>Orellano, Elsie A.</au><au>Rosado, Karolyna</au><au>Guido, Rafael V. C.</au><au>Andricopulo, Adriano D.</au><au>Soto, Gabriela O.</au><au>Rodríguez, José W.</au><au>Sanabria-Ríos, David J.</au><au>Carballeira, Néstor M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of the (5Z)-5-Pentacosenoic and 5-Pentacosynoic Acids as Novel HIV-1 Reverse Transcriptase Inhibitors</atitle><jtitle>Lipids</jtitle><date>2015-09-07</date><risdate>2015</risdate><volume>50</volume><issue>10</issue><spage>1043</spage><epage>1050</epage><pages>1043-1050</pages><issn>0024-4201</issn><eissn>1558-9307</eissn><abstract>The natural fatty acids (5 Z )-5-pentacosenoic and (9 Z )-9-pentacosenoic acids were synthesized for the first time in eight steps starting from either 4-bromo-1-butanol or 8-bromo-1-butanol and in 20-58% overall yields, while the novel fatty acids 5-pentacosynoic and 9-pentacosynoic acids were also synthesized in six steps and in 34-43% overall yields. The Δ 5 acids displayed the best IC 50’s (24-38 µM) against the HIV-1 reverse transcriptase (RT) enzyme, comparable to nervonic acid (IC 50 = 12 µM). The Δ 9 acids were not as effective towards HIV-RT with the (9 Z )-9-pentacosenoic acid displaying an IC 50 = 54 µM. Fatty acid chain length and position of the unsaturation was critical for the observed inhibition. Molecular modeling studies indicated the structural determinants underlying the biological activity of the most potent compounds. These results provide new insights into the structural requirements that must be present in fatty acids so as to enhance their inhibitory potential towards HIV-RT.</abstract><pmid>26345647</pmid><doi>10.1007/s11745-015-4064-2</doi></addata></record>
fulltext fulltext
identifier ISSN: 0024-4201
ispartof Lipids, 2015-09, Vol.50 (10), p.1043-1050
issn 0024-4201
1558-9307
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4841444
source Access via Wiley Online Library; SpringerNature Journals
title Synthesis of the (5Z)-5-Pentacosenoic and 5-Pentacosynoic Acids as Novel HIV-1 Reverse Transcriptase Inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T23%3A36%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%20the%20(5Z)-5-Pentacosenoic%20and%205-Pentacosynoic%20Acids%20as%20Novel%20HIV-1%20Reverse%20Transcriptase%20Inhibitors&rft.jtitle=Lipids&rft.au=Moreira,%20Lizabeth%20Gim%C3%A9nez&rft.date=2015-09-07&rft.volume=50&rft.issue=10&rft.spage=1043&rft.epage=1050&rft.pages=1043-1050&rft.issn=0024-4201&rft.eissn=1558-9307&rft_id=info:doi/10.1007/s11745-015-4064-2&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_4841444%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/26345647&rfr_iscdi=true